What is Male Infertility Market Scope?
Infertility in men can be caused by different factors and is typically evaluated by a semen analysis. Male infertility may be treated with medical, surgical, or assisted reproductive therapies depending on the underlying cause. Medical and surgical therapies are usually managed by a urologist who specializes in infertility. A reproductive endocrinologist may offer intrauterine inseminations (IUIs) or in vitro fertilization (IVF) to help overcome male factor infertility.
The Male Infertility market study is being classified and major geographies with country level break-up.
There are various companies that are exploring the market opportunities by investing in the new treatment and also expanding their footprints in new geographic regions by adopting various strategic initiatives such as mergers & acquisitions, expansions, investments, new product launches, and others. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Male Infertility market throughout the predicted period.
ASKA Pharmaceutical Co., Ltd. (Japan), Halotech DNA (Spain), Merck Serono (Germany), Cadila Healthcare (India), AbbVie (United States), Apricus Biosciences, Inc. (United States), Aytu BioScience (United States), Bristol Myers Squibb (United States), Coopersurgical, Inc. (United States) and Medical Electronic Systems (Israel) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are MedITEX (Germany) and Xytex Cryo International (United States).
Analyst at AMA have segmented the market study of Global Male Infertility market by Type, Application and Region.
On the basis of geography, the market of Male Infertility has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In April 2018, Sandstone Diagnostics, a medical device company focused on a data-driven approach to menís reproductive health, proudly announces the FDA 510(k) clearance and commercial launch of the Trakģ Volume Cup. The patent-pending Volume Cup is the first FDA-cleared device that allows men to measure semen volume and diagnose hypospermia, or low semen volume, at home.
Influencing Market Trend
- Surging Development and Commercialization of Hormonal Therapy
- Increasing Infertility Rate
- Rising Adoption of Assisted Reproductive Technologies (ART)
- Growing Sedentary Lifestyle across the Globe
- Governments Initiatives to Improve the Reimbursement Scenario for Infertility-related Treatments
- Increasing Healthcare Expenditure in Developing Countries
- High Cost of Procedures
- Social Taboos
- Impact of Repeated Failures in Treatments
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Male Infertility Treatment Provider, Government Regulatory and Research Organizations and End-Use Industries
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.